Cholinoreceptor autoantibodies in Sjögren sndrome

Journal of Dental Research

Volumn 86, Issue 9, 2007, Pages 832-836

  Reina, S ^a   Oman, B ^a   Anaya, J M ^b   Sterin Borda, L ^a,c   Borda, E ^a,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Autoantibodies; Cholinoceptor antibodies; PGE2; Sj gren syndrome; Submandibular gland

Indexed keywords

AUTOANTIBODY; CALCIUM; CYCLOOXYGENASE 2; IMMUNOGLOBULIN G; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; PROSTAGLANDIN E2;

ADULT; ANIMAL; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POSTMENOPAUSE; RAT; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND;

ADULT; ANIMALS; AUTOANTIBODIES; CALCIUM; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; MUSCARINIC AGONISTS; POSTMENOPAUSE; RATS; RECEPTORS, MUSCARINIC; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND;

EID: 34548731971     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600905     Document Type: Article

References (31)

1. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA (1996). Selective inhibition of COX-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672-2679.
2. Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E (1996) Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 104:454-459.
3. Bacman S, Berra A, Sterin-Borda L, Borda E (2001). Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome. Invest Ophthalmol Vis Sci 42:321-327.
4. Berra A, Sterin-Borda L, Bacman S, Borda E (2002). Role of salivary IgA in the pathogenesis of Sjögren syndrome. Clin Immunol 104:49-57.
5. Bley KR, Hunter JC, Eglen RM, Smith JA (1998). The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol Sci 19:141-147.
6. Cha S, Singson E, Cornelius J, Yagna JP, Knot HJ, Peck AB (2006). Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren syndrome-associated autoantibodies. J Rheumatol 33:296-306.
7. Chomczynski P, Sacchi N (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
8. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM (2006). Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 54:1165-1173.
9. Ferguson DB (1999). The flow rate and composition of human labial gland saliva. Arch Oral Biol 44(Suppl 1):S11-S14.
10. Fox RI (2005). Sjögren's syndrome. Lancet 366:321-331.
11. Graves DT, Jiang Y, Genco C (2000). Periodontal disease: bacterial virulence factors, host response and impact on systemic health. Curr Opin Infect Dis 13:227-232.
12. Kovacs L, Marczinovits I, Gyorgy A, Toth G, Dorgai L, Pal J, et al. (2005). Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjögren's syndrome. Rheumatology (Oxford) 44:1021-1025.
13. Leiros CP, Sterin-Borda L, Borda ES, Goin JC, Hosey MM (1997). Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J Biol Chem 272:12989-12993.
14. Li J, Ha YM, Ku NY, Choi SY, Lee SJ, Oh SB, et al. (2004). Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome. Lab Invest 84:1430-1438.
15. 2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 89:6147-6151.
16. Marczinovits I. Kovacs L, Gyorgy A, Toth GK, Dorgai L, Molnar J, et al. (2005). A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjögren's syndrome. J Autoimmun 24:47-54.
17. Moutsopoulos HM, Talal N (1987). Immunologic abnormalities in Sjögren syndrome. In: Sjögren's syndrome: clinical and immunological aspects. Talal N, Moutsopoulos HM, editors. Berlin: Springer-Verlag, pp. 258-265.
18. Offenbacher S, Collins JG, Arnold RR (1993). New clinical diagnostic strategies based on pathogenesis of disease. J Periodontal Res 28:523-535.
19. Pasinetti GM (2001 ). Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia. Arch Gerontol Geriatr 33:13-28.
20. Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda ES (1999). Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren syndrome antibodies. Clin Immunol 90:190-195.
21. Ravald N, List T (1998). Caries and periodontal conditions in patients with primary Sjögren's syndrome. Swed Dent J 22:97-103.
22. Reina S, Sterin-Borda L, Orman B, Borda E (2004). Human mAChR antibodies from Sjögren syndrome sera increase cerebral nitric oxide synthase activity and nitric oxide synthase mRNA level. Clin Immunol 113:193-202.
23. Reina S, Sterin-Borda L, Orman O, Borda E (2005). Autoantibodies against submandibular gland muscarinic cholinoceptor subtypes in primary Sjögren syndrome. Eur J Inflamm 3:135-141.
24. Sterin-Borda L, Ganzinelli S, Berra A, Borda E (2003). Novel insight into the mechanisms involved in the regulation of the ml muscarinic receptor, iNOS and nNOS mRNA levels. Neuropharmacology 45:260-269.
25. Tegeder I, Niederberger E, Vetter G, Brautigam L, Geisslinger G (2001). Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem 79:777-786.
26. Tominaga M, Migita K, Sano H, Fukui W, Kohno M, Tsubouchi Y, et al. (2000). Expression of cyclooxygenase-1 (COX-1) in labial salivary glands of Sjögren's syndrome. Clin Exp Immunol 122:459-463.
27. Tsubota K, Kaido M, Yagi Y, Fujihara T, Shimmura S (1999). Diseases associated with ocular surface abnormalities: the importance of reflex tearing. Br J Ophthalmol 83:89-91.
28. Vitali C, Bombardiert S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. (1993). Preliminary criteria for the classification of Sjögren's syndrome. Results from a prospective concerted action supported by the European Community. Arthritis Rheum 36:340-347.
29. Waterman SA, Gordon TP, Rischmueller M (2000). Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 43:1647-1654.
30. Williams TJ, Peck MJ (1977). Role of PG-mediated vasodilatation in inflammation. Nature 270:530-532.
31. Yuan J, Bowman AS, Aljamali M, Payne MR, Tucker JS, Dillwith JW, et al. (2000). Prostaglandin E(2)-stimulated secretion of protein in salivary glands of the lone star tick via a phosphoinositide signaling pathway. Insect Biochem Mol Biol 30:1099-1106.